AI-Driven Workflow for Electronic Common Technical Document (eCTD) Module 2-5 Compilation

Manual eCTD compilation is a high-cost, error-prone bottleneck that delays submissions and risks technical rejection. This custom workflow automates the assembly of Modules 2-5 by deploying orchestrated agents connected to source systems like Veeva Vault, Documentum, and clinical data warehouses. The architecture ingests source documents, applies jurisdiction-specific business rules for FDA or EMA, and performs continuous validation, cutting compilation time by over 70% and freeing regulatory operations staff from repetitive administrative assembly work.

Implementation requires integrating the orchestration layer with existing content management and publishing tools via APIs. The workflow includes mandatory human review gates for final medical and regulatory sign-off before automated publishing. Controls are built around version locking, audit trails for all agent actions, and real-time health scoring of the compilation progress. This creates a repeatable, audit-ready operating model that directly impacts submission readiness and first-cycle review success by ensuring technical compliance and data consistency.

This workflow automates the high-cost, error-prone manual compilation of eCTD Modules 2-5, which typically consumes weeks of regulatory operations labor. The operational upside comes from eliminating repetitive document retrieval, formatting, and consistency checking, directly reducing submission cycle times and validation failures. Savings are realized through labor leverage and the mitigation of costly last-minute rework, ensuring teams meet high-stakes regulatory deadlines with higher confidence.

Implementation connects specialized agents to enterprise systems like Veeva Vault, SAS, and LIMS via APIs or RPA. The Orchestrator manages the workflow state, while retrieval agents fetch source documents, and formatting agents apply regional templates (NDA/MAA). A validation agent performs continuous technical checks against health authority specifications. Controls include mandatory human review gates for high-risk changes, version locking, and a full audit trail integrated into the RIM system for defensible traceability and inspection readiness.

Phase 1 establishes a foundational orchestration layer using LangGraph or a custom Python service, connected to your core Document Management System (e.g., Veeva Vault, Documentum). This initial scope automates the retrieval and basic validation of source documents for a single, high-volume module like Module 2.7 (Clinical Overview). The goal is to prove the technical integration, deliver a 50-70% reduction in manual collation time for that module, and establish the human-in-the-loop review gates and audit logging required for GxP compliance before scaling.

Subsequent phases systematically expand the agentic layer's scope. Phase 2 integrates with clinical data warehouses and statistical computing environments (e.g., SAS, R) to automate the assembly of Clinical Study Reports (Module 2.5) and the complex data pooling for Integrated Summaries of Safety/Efficacy (Module 2.6). The final phase incorporates CMC (Module 3) and nonclinical (Module 4) sources from LIMS and ERP systems, culminating in a full cross-module validation agent that performs consistency checking and technical compliance validation against the eCTD specification before automated publishing via tools like Liquent or DocuBridge.

This workflow automates the high-cost, error-prone manual compilation of eCTD Modules 2-5, directly impacting submission cycle times and validation failure rates. It connects custom document-retrieval agents to source systems like Veeva Vault and Documentum, applies regional formatting rules via orchestration logic, and validates technical compliance against FDA/EMA specifications. The operational upside comes from reducing a multi-week, expert-driven process to days, freeing regulatory operations staff from administrative assembly and enabling faster response to deadlines. Savings are realized through labor leverage and reduced risk of costly submission rejections for technical errors.

Implementation requires a phased rollout, starting with Module 2.3 (Quality) to control risk before expanding to clinical and nonclinical modules. Each phase integrates with existing validation engines and includes mandatory human review checkpoints before document lock. Governance is enforced through the orchestrator, which logs all agent actions, data sources, and reviewer decisions into an immutable audit trail within the Regulatory Information Management (RIM) system. Monitoring focuses on exception rates, compilation time per module, and validation pass/fail metrics, allowing for continuous tuning of agent logic and retrieval accuracy before full-scale deployment.

Manual eCTD compilation is a high-cost, error-prone bottleneck, consuming weeks of expert labor and risking validation failures that delay submissions. A custom automation workflow eliminates this by orchestrating specialized agents to retrieve source documents from Veeva Vault or Documentum, apply jurisdiction-specific templates (FDA NDA vs. EMA MAA), and execute pre-submission technical checks. The architecture directly integrates with publishing engines like Liquent or Lorenz to render compliant PDFs, cutting compilation cycle times by over 70% and reducing administrative burden through repeatable, auditable processes.

Implementation requires an orchestration layer, such as LangGraph, to manage state and dependencies between retrieval, formatting, and validation agents. Critical controls include human-in-the-loop checkpoints for medical review, automated audit trails for data lineage, and continuous health scoring of the compilation pipeline. The workflow must handle exceptions—like missing source data or formatting conflicts—by routing them to designated queues for rapid resolution, ensuring the final package meets all FDA ESG or EMA Gateway technical specifications before automated transmission.